Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8067 |
Intermediate Similarity |
NPD8836 |
Approved |
0.7895 |
Intermediate Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7385 |
Intermediate Similarity |
NPD8833 |
Approved |
0.7385 |
Intermediate Similarity |
NPD8831 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8830 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7259 |
Intermediate Similarity |
NPD579 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD4240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1730 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD9084 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD9360 |
Approved |
0.7055 |
Intermediate Similarity |
NPD185 |
Approved |
0.7034 |
Intermediate Similarity |
NPD3696 |
Approved |
0.7034 |
Intermediate Similarity |
NPD193 |
Suspended |
0.7034 |
Intermediate Similarity |
NPD3695 |
Approved |
0.7025 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7025 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9289 |
Approved |
0.7015 |
Intermediate Similarity |
NPD76 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9288 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9292 |
Approved |
0.6959 |
Remote Similarity |
NPD250 |
Approved |
0.6959 |
Remote Similarity |
NPD166 |
Approved |
0.6959 |
Remote Similarity |
NPD249 |
Approved |
0.6928 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD78 |
Approved |
0.6884 |
Remote Similarity |
NPD9544 |
Approved |
0.6867 |
Remote Similarity |
NPD186 |
Discovery |
0.6867 |
Remote Similarity |
NPD195 |
Approved |
0.6853 |
Remote Similarity |
NPD1058 |
Discontinued |
0.685 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6795 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6794 |
Remote Similarity |
NPD8955 |
Approved |
0.6794 |
Remote Similarity |
NPD8954 |
Approved |
0.6776 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD171 |
Discontinued |
0.6688 |
Remote Similarity |
NPD283 |
Approved |
0.6667 |
Remote Similarity |
NPD300 |
Approved |
0.6623 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6603 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6603 |
Remote Similarity |
NPD242 |
Approved |
0.6603 |
Remote Similarity |
NPD338 |
Approved |
0.6577 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6569 |
Remote Similarity |
NPD578 |
Discontinued |
0.6561 |
Remote Similarity |
NPD339 |
Approved |
0.6556 |
Remote Similarity |
NPD9704 |
Approved |
0.6554 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6531 |
Remote Similarity |
NPD1120 |
Approved |
0.6531 |
Remote Similarity |
NPD1121 |
Approved |
0.6522 |
Remote Similarity |
NPD3083 |
Approved |
0.6522 |
Remote Similarity |
NPD580 |
Discontinued |
0.6519 |
Remote Similarity |
NPD169 |
Phase 2 |
0.6497 |
Remote Similarity |
NPD214 |
Approved |
0.6497 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.6493 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6483 |
Remote Similarity |
NPD282 |
Approved |
0.6479 |
Remote Similarity |
NPD281 |
Approved |
0.6478 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6449 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.6444 |
Remote Similarity |
NPD9359 |
Approved |
0.6444 |
Remote Similarity |
NPD9358 |
Approved |
0.6429 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.6403 |
Remote Similarity |
NPD307 |
Approved |
0.6389 |
Remote Similarity |
NPD1128 |
Approved |
0.6389 |
Remote Similarity |
NPD1127 |
Approved |
0.6379 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6375 |
Remote Similarity |
NPD217 |
Approved |
0.6375 |
Remote Similarity |
NPD218 |
Approved |
0.6375 |
Remote Similarity |
NPD216 |
Approved |
0.6375 |
Remote Similarity |
NPD219 |
Phase 3 |
0.6375 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.6358 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6357 |
Remote Similarity |
NPD9409 |
Discontinued |
0.635 |
Remote Similarity |
NPD9374 |
Approved |
0.635 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6349 |
Remote Similarity |
NPD8838 |
Approved |
0.6324 |
Remote Similarity |
NPD9373 |
Approved |
0.6323 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6316 |
Remote Similarity |
NPD1430 |
Approved |
0.6316 |
Remote Similarity |
NPD1431 |
Approved |
0.6284 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6272 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.6242 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6229 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6229 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6229 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6225 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6214 |
Remote Similarity |
NPD9606 |
Approved |
0.6207 |
Remote Similarity |
NPD1085 |
Approved |
0.6207 |
Remote Similarity |
NPD1775 |
Approved |
0.6205 |
Remote Similarity |
NPD7988 |
Suspended |
0.619 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.617 |
Remote Similarity |
NPD9607 |
Approved |
0.6169 |
Remote Similarity |
NPD1451 |
Approved |
0.6169 |
Remote Similarity |
NPD2179 |
Discontinued |
0.6168 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6165 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6159 |
Remote Similarity |
NPD9133 |
Approved |
0.6159 |
Remote Similarity |
NPD9628 |
Approved |
0.6154 |
Remote Similarity |
NPD4262 |
Discontinued |
0.6143 |
Remote Similarity |
NPD1368 |
Approved |
0.6136 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.6133 |
Remote Similarity |
NPD8827 |
Approved |
0.6119 |
Remote Similarity |
NPD9291 |
Approved |
0.6108 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.6098 |
Remote Similarity |
NPD5321 |
Phase 3 |
0.609 |
Remote Similarity |
NPD341 |
Approved |
0.609 |
Remote Similarity |
NPD340 |
Approved |
0.6062 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6027 |
Remote Similarity |
NPD4812 |
Phase 1 |
0.6023 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6023 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6012 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6 |
Remote Similarity |
NPD9086 |
Approved |
0.5987 |
Remote Similarity |
NPD9627 |
Approved |
0.5987 |
Remote Similarity |
NPD535 |
Approved |
0.5986 |
Remote Similarity |
NPD9366 |
Approved |
0.5986 |
Remote Similarity |
NPD515 |
Phase 1 |
0.597 |
Remote Similarity |
NPD8861 |
Approved |
0.597 |
Remote Similarity |
NPD8859 |
Approved |
0.597 |
Remote Similarity |
NPD8862 |
Approved |
0.5962 |
Remote Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.5954 |
Remote Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.5948 |
Remote Similarity |
NPD9551 |
Approved |
0.5948 |
Remote Similarity |
NPD9550 |
Approved |
0.5928 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.592 |
Remote Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.5917 |
Remote Similarity |
NPD2134 |
Approved |
0.5917 |
Remote Similarity |
NPD2136 |
Approved |
0.5917 |
Remote Similarity |
NPD2135 |
Approved |
0.5906 |
Remote Similarity |
NPD9571 |
Approved |
0.5903 |
Remote Similarity |
NPD9290 |
Approved |
0.5894 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5894 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5889 |
Remote Similarity |
NPD2630 |
Approved |
0.5889 |
Remote Similarity |
NPD2632 |
Approved |
0.5889 |
Remote Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD3697 |
Discontinued |
0.5878 |
Remote Similarity |
NPD8826 |
Approved |
0.5875 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.5875 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.5852 |
Remote Similarity |
NPD4716 |
Approved |
0.5844 |
Remote Similarity |
NPD6112 |
Approved |
0.5819 |
Remote Similarity |
NPD3593 |
Approved |
0.5819 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5817 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5782 |
Remote Similarity |
NPD798 |
Discontinued |
0.5779 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5775 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.5754 |
Remote Similarity |
NPD1692 |
Approved |
0.5752 |
Remote Similarity |
NPD1264 |
Phase 2 |
0.5732 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.5725 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD306 |
Approved |
0.5714 |
Remote Similarity |
NPD1335 |
Approved |
0.5706 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.5697 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.569 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.5689 |
Remote Similarity |
NPD2604 |
Approved |
0.5672 |
Remote Similarity |
NPD9193 |
Approved |
0.5672 |
Remote Similarity |
NPD9194 |
Approved |
0.5662 |
Remote Similarity |
NPD8566 |
Approved |
0.566 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.5659 |
Remote Similarity |
NPD8565 |
Clinical (unspecified phase) |
0.5658 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5649 |
Remote Similarity |
NPD5340 |
Clinical (unspecified phase) |
0.5636 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.5633 |
Remote Similarity |
NPD549 |
Approved |
0.5633 |
Remote Similarity |
NPD875 |
Clinical (unspecified phase) |
0.5625 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5607
|
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |